Shalby Limited — Important, 28-03-2025: General Updates

Shalby Limited's subsidiary, Shalby Medtech Limited, has allotted 7,50,00,000 equity shares at ₹10 each, totaling ₹75 Crore, by converting a loan into equity. Following this action, the paid-up share capital of Shalby Medtech increased to ₹275 Crore. This move enhances Shalby Limited's stake in its subsidiary, aligning with its strategy to fortify its operational base in medical devices. Investors may view this as a positive outlook, bolstering the subsidiary's financial robustness and market position, while also considering potential risks associated with further capital movements.